Heidelberg Pharma AG

Director's Dealing • Dec 19, 2016

News Details

Directors’ Dealings | 19 December 2016 11:12

DGAP-DD: WILEX AG english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

19.12.2016 / 11:11

The issuer is solely responsible for the content of this announcement.

---

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Name and legal form:	Curacyte GmbH i.L.

2. Reason for the notification

a) Position / status

Person closely associated with:
Title:	Dr.
First name:	Mathias
Last name(s):	Hothum
Position:	Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

WILEX AG

b) LEI

391200E09XYBYITR1W32

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A11QVV0

b) Nature of the transaction

Disposal

c) Price(s) and volume(s)

Price(s)	Volume(s)
1.84 EUR	1056756.16 EUR

d) Aggregated information

Price	Aggregated volume
1.8400 EUR	1056756.1600 EUR

e) Date of the transaction

2016-12-14; UTC+1

f) Place of the transaction

Outside a trading venue

---

19.12.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de

---

Language:	English
Company:	WILEX AG
	Grillparzerstr. 18
	81675 München
	Germany
Internet:	www.wilex.com

End of News	DGAP News Service